Circulating miRNA profiling to identify biomarkers of dysmetabolism

Biomarkers in Medicine

Volumn 6, Issue 6, 2012, Pages 729-742

  Tomaselli, Sara ^a   Panera, Nadia ^a   Gallo, Angela ^a   Alisi, Anna ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

circulating biomarkers; dyslipidemia nonalcoholic fatty liver disease; metabolic disorders; microarray; microRNAs; qRT PCR; quantitative reverse transcription PCR; RNA deep sequencing; RNA seq

Indexed keywords

ARGONAUTE 2 PROTEIN; ARGONAUTE PROTEIN; BIOLOGICAL MARKER; INTERLEUKIN ENHANCER BINDING FACTOR 2; INTERLEUKIN ENHANCER BINDING FACTOR 3; MICRORNA; POLYSTYRENE; PROTEIN LIN 14; PROTEIN LIN 28; RNA BINDING PROTEIN; RNA POLYMERASE II; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; BINDING AFFINITY; BIOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; DEGENERATIVE DISEASE; DIABETES MELLITUS; DNA METHYLATION; EARLY DIAGNOSIS; ENZYME ACTIVITY; FATTY ACID METABOLISM; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HIGH THROUGHPUT SEQUENCING; HISTONE MODIFICATION; HOST PATHOGEN INTERACTION; HUMAN; INSULIN RELEASE; INTRACELLULAR SIGNALING; LIPID METABOLISM; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DEVICE; METABOLIC DISORDER; MICROARRAY ANALYSIS; NON INVASIVE PROCEDURE; NONHUMAN; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; RNA BINDING; RNA DEGRADATION; RNA METABOLISM; RNA PROCESSING; RNA SEQUENCE; RNA TRANSCRIPTION; SYMPTOMATOLOGY;

ANIMALS; BIOLOGICAL MARKERS; GENETIC TECHNIQUES; HUMANS; METABOLIC DISEASES; MICRORNAS;

EID: 84870917660     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.12.91     Document Type: Review

References (118)

1. Pasquinelli AE. MicroRNAs and their targets: Recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 13, 271-282 (2012
2. Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res. 39, 6845-6853 (2011
3. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004
4. Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515-524 (2012
5. Yi R, Fuchs E. MicroRNAs and their roles in mammalian stem cells. J. Cell Sci. 124(PT11), 1775-1783 (2011
6. Corsini LR, Bronte G, Terrasi M et al. The role of microRNAs in cancer. Diagnostic and prognostic biomarkers and targets of therapies. Exp. Opin. Ther. Targets 16(SUPPL2), S103-S109 (2012
7. Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513-10518 (2008
8. Krützfeldt J, Stoffel M. MicroRNAs: A new class of regulatory genes affecting metabolism. Cell Metab. 4, 9-12 (2006
9. Lynn FC. Meta-regulation: MicroRNA regulation of glucose and lipid metabolism. Trends Endocrinol. Metab. 20, 452-459 (2009
10. Rottiers V, Näär AM. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13, 239-250 (2012
11. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854 (1993
12. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855-862 (1993
13. Reinhart BJ, Slack FJ, Basson M et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906 (2000
14. Pasquinelli AE, Reinhart BJ, Slack F et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86-89 (2000
15. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233 (2009
16. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: Tools for microRNA genomics. Nucleic Acids Res. 36(Database issue), D154-D158 (2008
17. Kozomara A, Griffiths-Jones S. miRBase: Integrating microRNA annotation and deepsequencing data. Nucleic Acids Res. 39(Database issue), D152-D157 (2011
18. Carbonell J, Alloza E, Arce P et al. A map of human microRNA variation uncovers unexpectedly high levels of variability. Genome Med. 4, 622012 (2012
19. Bernstein E, Kim SY, Carmell MA et al. Dicer is essential for mouse development. Nat. Genet. 35, 215-217 (2003
20. Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl Acad. Sci. USA 102, 10898-10903 (2005
21. Kanellopoulou C, Muljo SA, Kung AL et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 19, 489-501 (2005
22. Meola NV, Gennarino A, Banfi S. MicroRNAs and genetic diseases. Pathogenetics 2(1), 7 (2009
23. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874 (2011
24. Chen X, Ba Y, Ma L et al. Characterization of microRNAs in serum. A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006 (2008
25. Saini HK, Griffiths-Jones S, Enright AJ. Genomic analysis of human microRNA transcripts. Proc. Natl Acad. Sci. USA 104, 17719-17724 (2007
26. Lee Y, Kim M, Han JJ et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060 (2004
27. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10, 1957-1966 (2004
28. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139 (2009
29. Miyoshi K, Miyoshi T, Siomi H. Many ways to generate microRNA-like small RNAs: Non-canonical pathways for microRNA production. Mol. Genet. Genomics 284, 95-103 (2010
30. Westholm JO, Lai EC. Mirtrons: MicroRNA biogenesis via splicing. Biochimie 93, 1897-1904 (2011
31. Hutvagner G, Simard MJ. Argonaute proteins: Key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 9, 22-32 (2008
32. Eulalio A, Tritschler F, Izaurralde E. The GW182 protein family in animal cells: New insights into domains required for miRNA-mediated gene silencing. RNA 15, 1433-1442 (2009
33. Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl Acad. Sci. USA 103, 4034-4039 (2006
34. Behm-Ansmant I, Rehwinkel J, Doerks T, Stark A, Bork P, Izaurralde E. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. 20, 1885-1898 (2006
35. Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNAbinding sites in the 5́ UTR as in the 3́ UTR. Proc. Natl Acad. Sci. USA 104, 9667-9672 (2007
36. Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl Acad. Sci. USA 105, 14879-14884 (2008
37. Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and function. Thromb. Haemost. 107, 605-610 (2012
38. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610 (2010
39. Han L, Witmer PD, Casey E, Valle D, Sukumar S. DNA methylation regulates microRNA expression. Cancer Biol. Ther. 6, 1284-1288 (2007
40. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K. MicroRNAs and epigenetics. FEBS J. 278, 1598-1609 (2011
41. Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science 320, 97-100 (2008
42. Han J, Pedersen JS, Kwon SC et al. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 136, 75-84 (2009
43. Chendrimada TP, Gregory RI, Kumaraswamy E et al. TRBP recruits the Dicer complex to AGO2 for microRNA processing and gene silencing. Nature 436, 740-744 (2005
44. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. EMBO J. 25, 522-532 (2006
45. Ma E, MacRae IJ, Kirsch JF, Doudna JA. Autoinhibition of human Dicer by its internal helicase domain. J. Mol. Biol. 380, 237-243 (2008
46. Lehrbach NJ, Miska EA. Regulation of pre-miRNA processing. Adv. Exp. Med. Biol. 700, 67-75 (2010
47. Heo I, Joo C, Cho J, Ha M, Han J, Kim VN. Lin28 mediates the terminal uridylation of let-7 precursor microRNA. Mol. Cell. 32, 276-284 (2008
48. Diederichs S, Haber DA. Dual role for Argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131, 1097-1108 (2007
49. O'Carroll D, Mecklenbrauker I, Das PP et al. A Slicer-Independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 21, 1999-2004 (2007
50. Qi HH, Ongusaha PP, Myllyharju J et al. Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature 455, 421-424 (2008
51. Katoh T, Sakaguchi Y, Miyauchi K et al. Selective stabilization of mammalian microRNAs by 3́ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2.Genes Dev. 23, 433-438 (2009
52. Brandi BN, Akiko Hata A. Regulation of microRNA biogenesis. A miRiad of mechanisms. Cell Commun. Signal. 7, 18 (2009
53. Yang W, Chendrimada TP, Wang Q et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 13, 13-21 (2006
54. Kawahara Y, Megraw M, Kreider E et al. Frequency and fate of microRNA editing in human brain. Nucleic Acids Res. 36, 5270-5280 (2008
55. Alon S, Mor E, Vigneault F et al. Systematic identification of edited microRNAs in the human brain. Genome Res. 22, 1533-1540 (2012
56. Liu CG, Calin GA, Meloon B et al. An oligonucleotide microchip for genomewide microRNA profiling in human and mouse tissues. Proc. Natl Acad. Sci. USA 101, 9740-9774 (2004
57. Novoradovskaya N, Whitfield ML, Basehore LS et al. Universal Reference RNA as a standard for microarray experiments BMC Genomics 5, 20 (2004
58. Qavi AJ, Kindt JT, Bailey RC. Sizing up the future of microRNA analysis. Anal. Bioanal. Chem. 398, 2535-2549 (2010
59. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (2006
60. Petersen M, Wengel J. LNA: A versatile tool for therapeutics and genomics. Trends Biotechnol. 21, 74-81 (2003
61. Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: Approaches and considerations. Nat. Rev. Genet. 13(5), 358-369 (2012
62. Biscontin A, Casara S, Cagnin S et al. New miRNA labeling method for bead-based quantification BMC Mol. Biol. 11, 44 (2011
63. Metzker ML. Sequencing technologies -The next generation. Nat. Rev. Genet. 11, 31-46 (2010
64. Friedlander MR, Chen W, Adamidi C et al. Discovering microRNAs from deep sequencing data using miRDeep. Nat. Biotechnol. 26, 407-415 (2008
65. Weber JA, Baxter DH, Zhang S et al. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010 56, 1733-1741 (2010
66. Ciesla M, Skrzypek K, Kozakowska M, Loboda A, Jozkowicz A, Dulak J. MicroRNAs as biomarkers of disease onset. Anal. Bioanal. Chem. 401, 2051-2061 (2011
67. Valadi H, Ekstrom K, Bossios A et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007
68. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNAprotective protein by mammalian cells. Nucleic Acids Res. 38, 7248-7259 (2010
69. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. Plos One 7, e30679 (2012
70. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433 (2011
71. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 110, 483-495 (2012
72. Zampetaki A, Kiechl S, Drozdov I et al. Plasma microRNA profiling reveals loss of endothelial miR 126 and other microRNAs in Type 2 diabetes. Circ. Res. 107, 810-817 (2010
73. Li S, Zhu J, Zhang W et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 124, 175-184 (2011
74. Kosaka N, Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: Biomarkers or mediators of cardiovascular diseases? Arterioscler. Thromb. Vasc. Biol. 31, 2383-2390 (2011
75. Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol. 22, 125-132 (2012
76. Horton JD, Goldstein JL, Brown MS. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131 (2002
77. Flowers E, Froelicher ES, Aouizerat BE. MicroRNA regulation of lipid metabolism. Metabolism doi:10.1016/j. metabol.2012.04.009 (2012) (Epub ahead of print
78. Jopling C. Liver-specific microRNA-122: Biogenesis and function. RNA Biol. 9, 137-142 (2012
79. Krützfeldt J, Rajewsky N, Braich R et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005
80. Esau C, Davis S, Murray SF et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87-98 (2006
81. Elmén J, Lindow M, Schütz S et al. LNAmediated microRNA silencing in nonhuman primates. Nature 452, 896-899 (2008
82. Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research. Semin. Liver Dis. 32, 3-13 (2012
83. Cheung O, Puri P, Eicken C et al. Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression. Hepatology 48, 1810-1820 (2008
84. Song KH, Li T, Owsley E, Chiang JY. A putative role of microRNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes. J. Lipid Res. 51, 2223-2233 (2010
85. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid. Res. 51, 1513-1523 (2010
86. Rayner KJ, Suárez Y, Dávalos A et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010
87. Rayner KJ, Esau CC, Hussain FN et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478, 404-407 (2011
88. Esau CC, Hussain FN, Temel RE et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121, 2921-2931 (2011
89. Dávalos A, Goedeke L, Smibert P et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl Acad. Sci. USA 108, 9232-9237 (2011
90. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226-230 (2004
91. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. miR 375 targets 3́ phosphoinositide dependent protein kinase 1 and regulates glucose-Induced biological responses in pancreatic b-cells. Diabetes 57, 2708-2717 (2008
92. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR 29a and miR 29b contribute to pancreatic b cell specific silencing of monocarboxylate transporter 1 (Mct1). Mol. Cell. Biol. 31, 3182-3194 (2011
93. Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J. Gastroenterol. 17, 2536-2542 (2011
94. Tsai WC, Hsu PW, Lai TC et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49, 1571-1582 (2009
95. Lanford RE, Hildebrandt-Eriksen ES, Petri A et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201 (2010
96. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and nonalcoholic fatty liver disease. Plos One 6, e23937 (2011
97. Tryndyak VP, Latendresse JR, Montgomery B et al. Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- And folate-deficient diet. Toxicol. Appl. Pharmacol. 1, 52-59 (2012
98. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233 (2011
99. Ajit SK. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors 12, 3359-3369 (2012
100. Papageorgiou N, Tousoulis D, Androulakis E et al. The role of microRNAs in cardiovascular disease. Curr. Med. Chem. 19, 2605-2610 (2012
101. Hastings MJ, Palma J, Duelli DM. Sensitive PCR-based quantitation of cell-free circulating microRNAs. Methods doi:10.1016/j. ymeth.2012.07.026 (2012) (Epub ahead of print).
102. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid. Res. 51, 1513-1523 (2010
103. Rayner KJ, Suárez Y, Dávalos A et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010
104. Rayner KJ, Esau CC, Hussain FN et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478, 404-407 (2011
105. Esau CC, Hussain FN, Temel RE et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121, 2921-2931 (2011
106. Dávalos A, Goedeke L, Smibert P et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl Acad. Sci. USA 108, 9232-9237 (2011
107. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226-230 (2004
108. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. miR 375 targets 3́ phosphoinositide dependent protein kinase 1 and regulates glucose-Induced biological responses in pancreatic b-cells. Diabetes 57, 2708-2717 (2008
109. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR 29a and miR 29b contribute to pancreatic b cell specific silencing of monocarboxylate transporter 1 (Mct1). Mol. Cell. Biol. 31, 3182-3194 (2011
110. Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J. Gastroenterol. 17, 2536-2542 (2011
111. Tsai WC, Hsu PW, Lai TC et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49, 1571-1582 (2009
112. Lanford RE, Hildebrandt-Eriksen ES, Petri A et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201 (2010
113. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and nonalcoholic fatty liver disease. Plos One 6, e23937 (2011
114. Tryndyak VP, Latendresse JR, Montgomery B et al. Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- And folate-deficient diet. Toxicol. Appl. Pharmacol. 1, 52-59 (2012
115. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233 (2011
116. Ajit SK. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors 12, 3359-3369 (2012
117. Papageorgiou N, Tousoulis D, Androulakis E et al. The role of microRNAs in cardiovascular disease. Curr. Med. Chem. 19, 2605-2610 (2012
118. Hastings MJ, Palma J, Duelli DM. Sensitive PCR-based quantitation of cell-free circulating microRNAs. Methods doi:10.1016/j. ymeth.2012.07.026 (2012) (Epub ahead of print)